8-K: Datavault AI Secures $12M in Dilutive Convertible Notes

Datavault AI Inc. has entered into agreements to raise $12 million through the sale of senior secured convertible notes and exchange warrants for common stock, signaling significant dilution amidst financial challenges.

Summary

• Datavault AI Inc. (DVLT) entered into a Securities Purchase Agreement on August 4, 2025, to sell senior secured convertible notes for an aggregate purchase price of $12,000,000.
• The financing consists of two tranches: Initial Notes with an aggregate principal amount of $6,666,666 for a purchase price of $6,000,000, and Additional Notes with the same principal and purchase price.
• The Notes carry a 10% original issue discount (OID) and mature 18 months from issuance, with no interest accruing unless an event of default occurs, in which case interest will accrue at 12% per annum.
• Obligations under these Notes rank senior to all other existing indebtedness and equity of the Company.
• The Notes are convertible at an initial price of $1.00 per share, or an alternate conversion price equal to the greater of a $0.1019 floor price or 80% of the lowest volume weighted average price (VWAP) in the twenty trading days prior to conversion.
• The Company is required to use up to 20% of the proceeds from future financings to redeem the Notes at 105% of the aggregate principal amount being redeemed.
• Purchasers of the Notes have the right, but not the obligation, to participate in any subsequent debt or equity financing by the Company up to a maximum of 65% of such financing.
• The Company also entered into Exchange Agreements to exchange approximately 31 million common stock purchase warrants for the same number of common stock shares, subject to stockholder approval.
• Prior notes issued on April 3, 2025, and May 21, 2025, will be amended to revise their alternate conversion price from 90% of 10-day lowest VWAP to 80% of 20-day lowest VWAP.
• Maxim Group LLC will act as the placement agent, receiving an 8.0% fee of the gross proceeds raised in the offering and reimbursement of up to $15,000 for expenses.

Sentiment

Score: 3

Explanation: While the capital raise provides immediate liquidity, the terms are highly unfavorable and indicative of significant financial distress. The substantial dilution potential, high cost of capital, and explicit acknowledgment of ongoing losses and Nasdaq compliance issues suggest a very challenging outlook for existing shareholders.

Positives

• Secured $12 million in gross proceeds, providing crucial working capital for the Company's operations.
• The senior secured nature of the convertible notes provides a strong incentive for investors, potentially attracting necessary capital in a challenging market.
• The notes rank senior to all other existing indebtedness and equity, enhancing their attractiveness to the new investors.
• Purchasers have the right to participate in future financings up to 65%, which could provide a stable source of future capital if the Company performs well.

Negatives

• The financing involves a 10% Original Issue Discount, meaning the Company receives less cash than the principal amount of debt issued.
• A significant 8.0% placement agent fee, plus up to $15,000 in expenses, further reduces the net proceeds received by the Company.
• The alternate conversion price, which can go as low as $0.1019 per share, combined with the exchange of approximately 31 million warrants for common stock, indicates substantial potential for dilution for existing shareholders.
• The Company explicitly acknowledges recurring losses from operations, a net capital deficiency, and a need for additional capital, highlighting ongoing financial instability.
• The Company is facing Nasdaq continued listing requirements and has been notified of non-compliance, with no assurance of regaining or maintaining compliance.
• The Company acknowledges that hedging activities by purchasers could reduce the value of existing stockholders' equity interests.

Risks

• The market price for the Common Stock is particularly volatile given the Company’s status as a relatively unknown company with a small and thinly traded public float, and lack of profits.
• The Company has been notified by Nasdaq of its failure to comply with certain continued listing requirements and there is no assurance it will achieve interim milestones or maintain compliance.
• Recurring losses from operations and a net capital deficiency indicate ongoing financial instability and a high need for additional capital.
• Significant dilution for existing shareholders is expected from the conversion of the new notes and the exchange of approximately 31 million warrants.
• The alternate conversion price mechanism, which can drop to a floor of $0.1019, exposes existing shareholders to substantial dilution if the stock price declines.
• Failure to obtain stockholder approval for the issuance of conversion shares and the warrant exchange could prevent the full consummation of the financing and trigger events of default.
• The Company's ability to maintain eligibility for Form S-3 registration and listing on Nasdaq is a material risk.
• The Company may not be able to renew its existing insurance coverage or obtain similar coverage without a significant increase in cost.
• Monetary judgments exceeding $100,000 or defaults on other indebtedness greater than $100,000 could trigger an Event of Default.

Future Outlook

The Company's future outlook remains challenging, marked by recurring losses, a net capital deficiency, and ongoing efforts to regain Nasdaq listing compliance. The current financing provides working capital but introduces significant potential for shareholder dilution. The Company plans to file a proxy statement and seek stockholder approval for the note conversions and warrant exchanges, which are critical for the full realization of this financing. The Company will also continue to maintain its listing on Nasdaq and engage professional services for financial reporting and public relations.

Management Comments

• The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions.
• The Company confirms that its obligations under the Transaction Documents, including the obligation to issue Conversion Shares, are unconditional and absolute, not subject to set-off, counterclaim, delay, or reduction, regardless of dilutive effect.
• The Company acknowledges that one or more Purchasers may engage in hedging activities, which could reduce the value of existing stockholders' equity interests, and that such activities do not constitute a breach of the Transaction Documents.
• The Company acknowledges that it faces certain challenges, including market price volatility, Nasdaq listing compliance issues, recurring losses from operations, a net capital deficiency, and a need for additional capital.

Industry Context

This financing occurs within the broader context of the AI and data management industry, where companies often require substantial capital for research, development, and market penetration. For smaller, less established players like Datavault AI, securing capital can be challenging, often leading to reliance on more dilutive instruments like convertible notes. The terms of this financing reflect the Company's specific financial distress and market position, rather than a general industry trend of favorable capital access.

Comparison to Industry Standards

• The use of senior secured convertible notes is a common financing mechanism for growth-stage technology companies, particularly those with significant capital needs and limited access to traditional debt or less dilutive equity financing.
• The 10% Original Issue Discount and the 12% default interest rate are relatively high, suggesting a higher risk premium demanded by investors compared to more mature or financially stable companies in the tech sector.
• The alternate conversion price mechanism (80% of 20-day lowest VWAP with a $0.1019 floor) is a standard anti-dilution feature for investors in such instruments, but it is aggressive and can lead to substantial dilution for existing shareholders if the stock price declines, a common outcome for companies facing Nasdaq compliance issues and recurring losses.
• The exchange of approximately 31 million warrants for common stock is a significant equity issuance, comparable to large capital raises seen in distressed or rapidly expanding companies, but in this case, it adds to the immediate dilutive impact.
• The 65% participation right in future financings for the purchasers is a strong investor protection, potentially limiting the Company's flexibility in future capital raises and potentially making it harder to attract new investors on more favorable terms.
• Nasdaq listing compliance issues, recurring losses, and net capital deficiencies are common challenges for smaller public companies, but the explicit disclosure of these issues underscores the Company's precarious financial position compared to industry leaders.

Corporate Governance

Stakeholder Impact

• Shareholders will experience significant dilution due to the issuance of convertible notes at a discount and the exchange of approximately 31 million warrants for common stock. The alternate conversion price mechanism could lead to further substantial dilution if the stock price declines.
• New noteholders benefit from senior secured status, a 10% OID, and a right to participate in future financings, positioning them favorably relative to existing equity and other debt holders.
• The Company gains critical working capital, but at a high cost and with restrictive covenants that may limit future strategic flexibility, such as limits on asset sales and other investments.

Next Steps

• Initial Closing of the notes is expected to occur on or about August 5, 2025.
• The Company must mail a definitive information statement on Schedule 14(c) to obtain stockholder approval for the issuance of conversion shares and exchange shares.
• The Additional Closing for the second tranche of notes will occur on or after 20 calendar days after the mailing of the Schedule 14(c) information statement.
• The Company is required to file a proxy statement for Nasdaq Stockholder Approval within 15 days of the Initial Closing Date.
• A special meeting of stockholders for Nasdaq Stockholder Approval must be held no later than 45 days after the Initial Closing Date.
• The Company will file a Current Report on Form 8-K, including the Transaction Documents as exhibits, by the Disclosure Time (shortly after the filing).

Key Dates

Recommendation

The terms of this financing are highly unfavorable for existing shareholders, indicating severe financial distress. The significant dilution from the convertible notes (issued at a 10% discount with a low conversion floor) and the exchange of 31 million warrants will substantially dilute existing equity. The high placement agent fees further erode the net proceeds. The Company's explicit acknowledgment of recurring losses, net capital deficiency, and ongoing Nasdaq compliance issues points to fundamental business challenges that this dilutive financing does not resolve, but rather exacerbates the burden on current equity holders. A seasoned investor would likely view this as a distressed financing event, signaling a need to exit the position.

Keywords

Convertible Notes, Capital Raise, Dilution, SEC Filing, Nasdaq Compliance, Financial Distress, Debt Financing, Warrant Exchange, AI, Data Management